Pharmacovigilance Pv And Drug Safety Software Market Size And Share

  • Report Code : TIPHC00002557
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Pharmacovigilance and Drug Safety Software Market Size, Segments, and Trends by 2031

Buy Now

Pharmacovigilance and Drug Safety Software Market Report Pharmacovigilance and Drug Safety Software Market Scope and Analysis Pharmacovigilance and Drug Safety Software Market Size and Share

Pharmacovigilance and Drug Safety Software Market: Strategic Insights

Pharmacovigilance and Drug Safety Software Market

  • CAGR (2023 - 2031)
    6.7%
  • Market Size 2023
    US$ 214.39 Million
  • Market Size 2031
    US$ 359.30 Million

Market Dynamics

GROWTH DRIVERS
  • Rise in Incidences of Adverse Drug Reactions
  • Globalization of Pharmacovigilance
  • Surge in Drug Development Spending
FUTURE TRENDS
  • Cloud-Based Pharmacovigilance, Drug Safety Software
OPPORTUNITIES
  • Integration of Software with AI, ML, and NLP

Key Players

  • ArisEurope
  • ICON plc
  • Syneos Health
  • Accenture
  • IQVIA
  • Genpact
  • Cognizant
  • Paraxel International Corporation
  • Laboratory Corporation of America Holdings
  • Max Application

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Offering
  • Software
  • Services
Deployment
  • Cloud
  • On Premises
Enterprise Size
  • Large Enterprises
  • SMEs
Form
  • Standard
  • Customized